Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Jul 9;64(1):51.
doi: 10.1186/s42358-024-00391-x.

Recommendations on cutaneous and hematological manifestations of Sjögren's disease by the Brazilian Society of Rheumatology

Alisson Pugliesi  1 , Danielle Christinne Soares do Egypto  2 , Guilherme Duffles  3 , Diego Ustárroz Cantali  4 , Sandra Gofinet Pasoto  5 , Fabiola Reis Oliveira  6 , Valeria Valim  7 , Maria Lucia Lemos Lopes  8 , Samira Tatiyama Miyamoto  9 , Marilena Leal Mesquita Silvestre Fernandes  10 , Sonia Cristina de Magalhães Souza Fialho  11 , Aysa César Pinheiro  12 , Laura Caldas Dos Santos  13 , Simone Appenzeller  14 , Sandra Lucia Euzébio Ribeiro  15 , Tatiana Nayara Libório-Kimura  16 , Maria Carmen Lopes Ferreira Silva Santos  17 , Juliana D Agostino Gennari  18 , Roberta Pernanbuco  19 , Karina Gatz Capobiano  20 , Vinicius Tassoni Civile  21   22   23 , Ana Carolina Pereira Nunes Pinto  21   22   24 , César Ramos Rocha-Filho  21 , Aline Pereira da Rocha  21   22 , Virginia Fernandes Moça Trevisani  21   22   25
Affiliations
Meta-Analysis

Recommendations on cutaneous and hematological manifestations of Sjögren's disease by the Brazilian Society of Rheumatology

Alisson Pugliesi et al. Adv Rheumatol. .

Abstract

Sjogren's disease (SjD) is an autoimmune disease that is characterized not only by the sicca symptoms it causes but also by its systemic nature, which is capable of several and not yet fully understood extraglandular manifestations. To gain a clearer understanding of these manifestations as well as a better practical approach, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of the extraglandular manifestations present in ESSDAI (EULAR Sjogren´s syndrome disease activity index), followed by a voting panel with recommendations for clinical practice. This publication is complementary to others already published and covers cutaneous and hematological manifestations, with prevalence data generated by a meta-analysis of 13 clinical or laboratory manifestations and 6 clinical management recommendations.

PubMed Disclaimer

References

    1. Moutsopoulos HM, Chused TM, Mann DL, Klippel JH, Fauci AS, Frank MM, et al. Sjögren’s syndrome (Sicca syndrome): current issues. Ann Intern Med. 1980 Feb;92(2 Pt 1):212–26. https://doi.org/10.7326/0003-4819-92-2-212 . - DOI - PubMed
    1. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren’s syndrome. Semin Arthritis Rheum. 2000 Apr;29(5):296–304. https://doi.org/10.1016/s0049-0172(00)80016-5 . - DOI - PubMed
    1. Beydon M, McCoy S, Nguyen Y, Sumida T, Mariette X, Seror R. Epidemiology of Sjögren syndrome. Nat Rev Rheumatol. 2024 Mar;20(3):158–69. https://doi.org/10.1038/s41584-023-01057-6 . - DOI - PubMed
    1. Valim V, Zandonade E, Pereira AM, de Brito Filho OH, Serrano EV, Musso C, et al. Primary Sjögren’s syndrome prevalence in a major metropolitan area in Brazil. Rev Bras Reumatol. 2013 Feb;53(1):24–34. - PubMed
    1. Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sjögren syndrome. Nat Rev Dis Primers. Jul 2016;2:16047. https://doi.org/10.1038/nrdp.2016.47 . - DOI - PubMed

LinkOut - more resources